Sign Up Quick Summary Retatrutide is an investigational weight loss medication currently in late-stage clinical trials that works by targeting three different hormone receptors simultaneously, making it the first triple agonist in its class with remarkable potential for treating obesity
J Pediatr Gastroenterol Nutr 59:642652 Jiang Y, Huang W, Sun X, Yang X, Wu Y, Shi J, Zheng J, Fan S, Liu J et al (2022) DTX-P7, a peptidedrug conjugate, is highly effective for non-small cell lung cancer
The active (reduced) form is full of vigor and ready to do some heavy lifting
Which autoimmune conditions respond to GLP-1 therapy Not every autoimmune condition has equal evidence
Komolmit et al [60] reported that vitamin D suppressed expression of CXCL10 from monocytes in vitro
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion